340 related articles for article (PubMed ID: 8525252)
1. [Ulcerative colitis and pericarditis. The role of mesalazine hypersensitivity].
Loizeau E
Rev Med Suisse Romande; 1995 Nov; 115(11):935-8. PubMed ID: 8525252
[No Abstract] [Full Text] [Related]
2. [Pentasa (mesalazine) and pregnancy].
Jonville-Bera AP; Soyez C; Fignon A; Moraine C; Berger C; Autret E
Therapie; 1994; 49(5):443-5. PubMed ID: 7855761
[TBL] [Abstract][Full Text] [Related]
3. [Mesalazine].
Engelhardt K; Mohr K
Dtsch Med Wochenschr; 1995 May; 120(21):769-70. PubMed ID: 7781502
[No Abstract] [Full Text] [Related]
4. Pleuropericarditis related to the use of mesalamine.
Gujral N; Friedenberg F; Friedenberg J; Gabriel G; Kotler M; Levine G
Dig Dis Sci; 1996 Mar; 41(3):624-6. PubMed ID: 8617147
[No Abstract] [Full Text] [Related]
5. Folliculitis and mesalamine.
Lizasoain J; Rubio FA; Erdozain JC; Olveira A; Conde P
Am J Gastroenterol; 1996 Apr; 91(4):819-20. PubMed ID: 8677969
[No Abstract] [Full Text] [Related]
6. [Pericarditis during inflammatory bowel diseases. Extra-intestinal or iatrogenic complication?].
Heresbach D; Rabot A; Génetet N; Marteau P; Stéphan C; Bretagne JF; Gosselin M
Gastroenterol Clin Biol; 1994; 18(8-9):782-5. PubMed ID: 7875451
[TBL] [Abstract][Full Text] [Related]
7. [Mesalazine-induced acute pericarditis].
Sierra Ausín M; Rascarachi G; Díez Rodríguez R; Arias Rodríguez L; Del Pozo Maroto E; Muñoz Núñez F
Gastroenterol Hepatol; 2010 Apr; 33(4):338-9. PubMed ID: 20005014
[No Abstract] [Full Text] [Related]
8. Mesalamine-induced lung toxicity.
Bitton A; Peppercorn MA; Hanrahan JP; Upton MP
Am J Gastroenterol; 1996 May; 91(5):1039-40. PubMed ID: 8633548
[TBL] [Abstract][Full Text] [Related]
9. Pleuropericarditis in a patient with ulcerative colitis in longstanding 5-aminosalicylic acid therapy.
Iaquinto G; Sorrentini I; Petillo FE; Berardesca G
Ital J Gastroenterol; 1994 Apr; 26(3):145-7. PubMed ID: 8061342
[TBL] [Abstract][Full Text] [Related]
10. Hypersensitivity to 5-aminosalicylic acid in patients with ulcerative colitis.
Niv Y
Isr J Med Sci; 1987 Nov; 23(11):1161-3. PubMed ID: 3436802
[No Abstract] [Full Text] [Related]
11. [False melanuria in a female patient treated with 5-ASA for ulcerative colitis].
Cuende JI; Gómez MT; García M; Pérez IJ
Med Clin (Barc); 1995 May; 104(20):798. PubMed ID: 7783478
[No Abstract] [Full Text] [Related]
12. Sulfasalazine-induced pericarditis in a patient with ulcerative colitis without recurrence when switching to mesalazine.
Perrot S; Aslangul E; Szwebel T; Gadhoum H; Romnicianu S; Le Jeunne C
Int J Colorectal Dis; 2007 Sep; 22(9):1119-21. PubMed ID: 17440739
[TBL] [Abstract][Full Text] [Related]
13. Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis.
Pruitt R; Hanson J; Safdi M; Wruble L; Hardi R; Johanson J; Koval G; Riff D; Winston B; Cross A; Doty P; Johnson LK
Am J Gastroenterol; 2002 Dec; 97(12):3078-86. PubMed ID: 12492193
[TBL] [Abstract][Full Text] [Related]
14. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
Nakajima H; Munakata A; Yoshida Y
J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
[TBL] [Abstract][Full Text] [Related]
15. Mesalamine (5-aminosalicylic acid) therapy well tolerated in a patient with aspirin hypersensitivity and ulcerative colitis.
Murphy SJ; Mayer L; Abreu MT
J Clin Gastroenterol; 2011 Jan; 45(1):83-4. PubMed ID: 20535023
[No Abstract] [Full Text] [Related]
16. A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.
Levine DS; Riff DS; Pruitt R; Wruble L; Koval G; Sales D; Bell JK; Johnson LK
Am J Gastroenterol; 2002 Jun; 97(6):1398-407. PubMed ID: 12094857
[TBL] [Abstract][Full Text] [Related]
17. [Myopericarditis in a patient with ulcerative colitis treated with mesalazine].
Martín M; Santamarta E; de la Iglesia JM; Saiz A
Med Clin (Barc); 2010 Jan; 134(1):43-4. PubMed ID: 19423137
[No Abstract] [Full Text] [Related]
18. [Pharmacological bases of therapy with 5-ASA].
Beltrán B; Martínez-Cuesta MA; Calatayud S; Hinojosa J; Esplugues JV
Gastroenterol Hepatol; 1997; 20(6):322-34. PubMed ID: 9296850
[No Abstract] [Full Text] [Related]
19. Nephrotic syndrome from 5-ASA for ulcerative colitis? Complicated by carcinoma of the colon and sclerosing cholangitis.
Fornaciari G; Maccari S; Borgatti PP; Rustichelli R; Amelio N; Lattuada I; Plancher AC
J Clin Gastroenterol; 1997 Jan; 24(1):37-9. PubMed ID: 9013349
[TBL] [Abstract][Full Text] [Related]
20. [Treatment and recurrence prevention ulcerative colitis].
Schölmerich J
Internist (Berl); 1995 Dec; 36(12):1124-32. PubMed ID: 8567217
[No Abstract] [Full Text] [Related]
[Next] [New Search]
